Q2 2024 Earnings Summary
Reported on Aug 1, 2024 (After Market Close)
Pre-Earnings Price$91.23Last close (Aug 1, 2024)
Post-Earnings Price$89.50Open (Aug 2, 2024)
Price Change
$-1.73(-1.90%)
- Disciplined M&A strategy enhances shareholder value, as Ingersoll Rand walked away from a large acquisition due to valuation concerns, demonstrating effective capital allocation.
- Acquisition of CAPS expands footprint in Australia, providing access to a large install base and strong customer relationships, and opening new market opportunities.
- Life Sciences business shows strong growth and profitability, with margins comparable to the Precision Tech segment, enhanced by the ILC Dover acquisition, boosting overall profitability.
Research analysts covering Ingersoll Rand.